• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11236

【品名】4-Nitrophenol; p-Nitrophenol

【CA登记号】100-02-7

【 分 子 式 】C6H5NO3

【 分 子 量 】139.11064

【元素组成】C 51.8% H 3.62% N 10.07% O 34.5%

与该中间体有关的原料药合成路线共 27 条

合成路线1

该中间体在本合成路线中的序号:(VIII)

A shorter synthetic pathway is through the condensation of the above chlorohydrin (II) with m-cyanobenzyloxyaniline (X), prepared by alkylation of p-nitrophenol (VIII) with m-cyanobenzyl bromide (VII) in the presence of KI and further reduction of the nitro group with Fe-NH4Cl, then cyclization with ethyl carbonate. Cimoxatone can also be obtained by opening glycidol (XI) with m-cyanobenzyloxyaniline (X) in ethanol under reflux, and cyclizing with ethyl carbonate (A) to obtain a 5-hydroxymethyl-2-oxazolidinone (XIII), which is methylated by CH3I under phase-transfer catalysis.

1 Ancher, J.F.; Bourgery, G.; Dostert, P.; Douzon, C.; Guerret, P.; Lacour, A.; Laglois, M.; Nouvelles oxazolidinones, oxazolidinethiones et pyrrilidinones, leur procédé de préparation et leur application en thérapeutique. FR 2428032; JP 55051064; JP 56167666 .
2 Ancher, J.F.; Cimoxatone. Drugs Fut 1984, 9, 6, 412.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 17470 diethyl carbonate; diethylcarbonate 105-58-8 C5H10O3 详情 详情
(II) 34214 1-chloro-3-methoxy-2-propanol 4151-97-7 C4H9ClO2 详情 详情
(VII) 13244 alpha-Bromo-m-tolunitrile; 3-(Bromomethyl)benzonitrile 28188-41-2 C8H6BrN 详情 详情
(VIII) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(IX) 34216 3-[(4-nitrophenoxy)methyl]benzonitrile C14H10N2O3 详情 详情
(X) 34217 3-[(4-aminophenoxy)methyl]benzonitrile C14H12N2O 详情 详情
(XI) 29648 2-oxiranylmethanol 556-52-5 C3H6O2 详情 详情
(XII) 34218 3-([4-[(2,3-dihydroxypropyl)amino]phenoxy]methyl)benzonitrile C17H18N2O3 详情 详情
(XIII) 34219 3-([4-[5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenoxy]methyl)benzonitrile C18H16N2O4 详情 详情
(XIV) 34220 3-([4-[(2-hydroxy-3-methoxypropyl)amino]phenoxy]methyl)benzonitrile C18H20N2O3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IV)

N-carbobenzyloxy-L-glutamic acid (I) is converted to the anhydride (II). Reaction of (II) with benzyl alcohol gives a mixture of half esters from which the halt ester (III) is isolated as the dicyclohexylamine salt. (III) is esterified with 4-nitrophenol (IV) with the aid of dicyclohexyl carbodiimide and the product (V) is reacted with taurine (VI). Deprotection of the resulting peptide (VII) by catalytic debenzylation affords glutaurine.

1 Feuer, L.; et al. (Chinoin Pharmaceutical and Chemical Works Co., Ltd.); Method of preparing gamma-L-glutamyl taurine. US 4110441 .
2 Nogradi, M.; Glutaurine. Drugs Fut 1984, 9, 2, 110.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29987 N-[(benzyloxy)carbonyl]glutamic acid 1155-62-0 C13H15NO6 详情 详情
(II) 29988 benzyl 2,6-dioxotetrahydro-2H-pyran-3-ylcarbamate C13H13NO5 详情 详情
(III) 29989 5-(benzyloxy)-4-[[(benzyloxy)carbonyl]amino]-5-oxopentanoic acid 65706-99-2 C20H21NO6 详情 详情
(IV) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(V) 29990 1-benzyl 5-(4-nitrophenyl) 2-[[(benzyloxy)carbonyl]amino]pentanedioate C26H24N2O8 详情 详情
(VI) 29991 2-ammonio-1-ethanesulfonate C2H7NO3S 详情 详情
(VII) 29992 2-[(5-(benzyloxy)-4-[[(benzyloxy)carbonyl]amino]-5-oxopentanoyl)amino]-1-ethanesulfonic acid C22H26N2O8S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

The reaction of 4-nitrophenol (I) with acetic anhydride in aqueous NaOH gives the corresponding acetate (II), which is submitted to a Fries migration with AlCl3 in nitrobenzene at 140 C to yield the acetophenone (III). The condensation of (III) with epichlorohydrin (IV) by means of K2CO3 affords the adduct (V), which is treated with tert-butylamine (VI) in water to obtain the aminoisopropanol derivative (VII). The reduction of the nitro group of (VII) with H2 over Pd/C in methanol gives the corresponding amino derivative (VIII), which is finally condensed with N,N-diethylcarbamoyl chloride (IX) by means of TEA in THF to yield the target urea.

1 Joshi, R.A.; et al.; A new and improved process for celiprolol hydrochloride. Org Process Res Dev 2001, 5, 2, 176.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(II) 50841 4-Nitrophenyl acetate; Acetic acid 4-nitrophenyl ester; p-Nitrophenyl acetate 830-03-5 C8H7NO4 详情 详情
(III) 50842 1-(2-hydroxy-5-nitrophenyl)-1-ethanone C8H7NO4 详情 详情
(IV) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(V) 50843 1-[5-nitro-2-(2-oxiranylmethoxy)phenyl]-1-ethanone C11H11NO5 详情 详情
(VI) 17895 2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine 75-64-9 C4H11N 详情 详情
(VII) 50844 1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-nitrophenyl]-1-ethanone C15H22N2O5 详情 详情
(VIII) 33819 1-[5-amino-2-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1-ethanone C15H24N2O3 详情 详情
(IX) 33816 N,N'-Diethylcarbamoyl chloride; 1-[(chlorocarbonyl)(ethyl)amino]ethane 88-10-8 C5H10ClNO 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

The reaction of 4-nitrophenol (I) with 2-chloroethyl isocyanate (II) in pyridine leads to the activated carbamate (III), which is nitrosated by reacting with nitrosyl chloride in pyridine at -20 C to yield 4-nitrophenyl N-(2-chloroethyl)-N-nitrosocarbamate (IV). The nitrosated molecule (IV) is reacted with 2-(methylthio)ethylamine (V) in THF at ordinary temperature affording the sulfure urea (VI), which is then oxidized to the sulfonyl compound (VII) by hydrogen peroxide in formic acid at 50 C.

1 Godeneche, D.; Imbach, J.-L.; Madelmont, J.-C.; Meyniel, G.; Moreau, M.-F.; Oiry, J.; Parry, D. (CNRS (Centre National de la Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale)); Novel nitrosourea cpds. Process of preparation. Compsns. based on these cpds. useful in anticancer chemotherapy. EP 0185020; FR 2562890; JP 1988502269; WO 8504655 .
2 Madelmont, J.-C.; Godeneche, D.; Moreau, M.-F.; Parry, D.; Meyniel, G.; Oiry, J.; Imbach, J.-L. (CNRS (Centre National de la Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale)); Nitrosoureas compounds, preparation thereof and utilization thereof in anticancerous. US 5001158 .
3 Meyniel, G.; Duprat, J.; Mathe, G.; Plagne, R.; Godeneche, D.; Parry, D.; Madelmont, J.C.; Chabard, J.L.; New cysteamin(2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor results. J Med Chem 1985, 28, 9, 1346-50.
4 Madelmont, J.C.; Cystemustine. Drugs Fut 1994, 19, 1, 27.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(II) 11237 1-Chloro-2-isocyanatoethane; 2-Chloroethyl isocyanate 1943-83-5 C3H4ClNO 详情 详情
(III) 11238 4-nitrophenyl N-(2-chloroethyl)carbamate C9H9ClN2O4 详情 详情
(IV) 11239 4-nitrophenyl 1-(2-chloroethyl)-2-oxo-1-hydrazinecarboxylate C9H8ClN3O5 详情 详情
(V) 11240 2-(Methylsulfanyl)ethylamine; 2-(Methylthio)ethylamine; 2-(Methylsulfanyl)-1-ethanamine 18542-42-2 C3H9NS 详情 详情
(VI) 11241 1-(2-Chloroethyl)-N-[2-(methylsulfanyl)ethyl]-2-oxo-1-hydrazinecarboxamide C6H12ClN3O2S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

The estrification of L-trans-epoxysuccinic acid hemi-ethyl ester (I) with 4-nitrophenol (II) by means of dicyclohexylcarbodiimide (DCC) gives the corresponding p-nitrophenyl ester (III), which is then condensed with N-isoamyl L-leucinamide (IV).

1 Soda, K.; et al. (Taisho Pharmaceutical Co., Ltd.); Trans-epoxysuccinic acid derivative. JP 60174777 .
2 Castaner, J.; Prous, J.; EST. Drugs Fut 1986, 11, 11, 927.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 24344 (2S,3S)-3-(ethoxycarbonyl)-2-oxiranecarboxylic acid C6H8O5 详情 详情
(II) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(III) 24346 2-ethyl 3-(4-nitrophenyl) (2S,3S)-2,3-oxiranedicarboxylate C12H11NO7 详情 详情
(IV) 24347 2-amino-N-isopentyl-4-methylpentanamide C11H24N2O 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XIX)

The optical resolution of racemic 2-benzylsuccinic acid (XV) using the chiral amines (R)-1-phenylethylamine (VII), (R)-1-(1-naphthyl)ethylamine (XIV) or (S)-1-phenyl-2-(4-tolyl)ethylamine (XVI) is carried out by fractional crystallization of the corresponding diastereomeric salts and treatment with 2N HCl, providing the desired enantiomer 2(S)-benzylsuccinic acid (XVII). Reaction of (XVII) with SOCl2 gives the corresponding acyl chloride (XVIII), which is treated with 4-nitrophenol (XIX) and TEA in dichloromethane to yield the activated diester (XX). The regioselective reaction of (XX) with cis-perhydroisoindole (V) in dichloromethane affords the monoamide (XXI), which by reaction with HCl and methanol provides the corresponding methyl ester (XXII). This ester is hydrolyzed with NaOH to the previously described chiral succinamic acid (XIII), which is finally converted into its calcium salt.

1 Castaner, R.M.; Sorbera, L.A.; Leeson, P.A.; Castaner, J.; Mitiglinide Calcium Hydrate. Drugs Fut 2000, 25, 10, 1034.
2 Mukaiyama, Y.; Hokari, H.; Kamijo, T.; Yanagi, T.; Yamaguchi, T.; Yamamoto, I.; Preparation of optically active succinic acid derivatives. II. Efficient and practical synthesis of KAD-1229. Chem Pharm Bull 1998, 46, 2, 337-340.
3 Yamaguchi, T.; et al.; Synthesis of KAD-1229, a succinic acid derivative with optical activity. 118th Annu Meet Pharmaceut Soc Jpn (March 31 1998, Kyoto) 1998, Abst 31(XP)9-9.
4 Yamaguchi, T.; Kamijo, T.; Yanagi, T. (Kissei Pharmaceutical Co., Ltd.); Process for producing optically active benzylsuccinic acid and intermediate therefor. WO 9832727 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 41059 (3aR,7aS)octahydro-1H-isoindole C8H15N 详情 详情
(VII) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(XIII) 41064 (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid C19H25NO3 详情 详情
(XIV) 17443 (1R)-1-(1-naphthyl)ethylamine; (1R)-1-(1-naphthyl)-1-ethanamine 3886-70-2 C12H13N 详情 详情
(XV) 41066 2-benzylsuccinic acid C11H12O4 详情 详情
(XVI) 41067 (1S)-2-(4-methylphenyl)-1-phenylethylamine; (1S)-2-(4-methylphenyl)-1-phenyl-1-ethanamine 30339-30-1 C15H17N 详情 详情
(XVII) 41068 (2S)-2-benzylbutanedioic acid C11H12O4 详情 详情
(XVIII) 41069 (2S)-2-benzylbutanedioyl dichloride C11H10Cl2O2 详情 详情
(XIX) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(XX) 41070 bis(4-nitrophenyl) (2S)-2-benzylbutanedioate C23H18N2O8 详情 详情
(XXI) 41071 4-nitrophenyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate C25H28N2O5 详情 详情
(XXII) 41072 methyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate C20H27NO3 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

Treatment of 4-nitrophenol (I) with propyl iodide derivative (II) and K2CO3 in DMF, followed by reduction with hydrazine hydrate, FeCl3 and activated carbon affords (III). Conversion of aniline derivative (III) into phenylcarbamate (IV) by means of PhOCOCl and treatment of (IV) with hydrazine hydrate yields semicarbazide (V), which is then subjected to cyclization with formamidine (VI) to give triazolone derivative (VII). Benzyl (S)-lactate (VIII) is converted to triflate (IX) by means of Tf2O in the presence of DIEA and its reaction with triazolone (VII) and NaH in DMF provides derivative (X). Debenzylation of (X) by hydrogenolysis over Pd/C followed by treatment with oxalyl chloride in CH2Cl2/DMF furnishes chloride (XI), which reacts with 1,3-difluorobenzene (XII) in CH2Cl2 in the presence of AlCl3 to yield intermediate (XIII).

1 Tamura, N.; Okonogi, K.; Hayashi, R.; Matsushita, Y.; Kitazaki, T.; Tasaka, A.; Itoh, K.; Optically active antifungal azoles.VI. Synthesis and antifungal activity of N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-N'-(4-substituted phenyl)-3(2H,4H)-1,2,4-triazolones and 5(1H,4H)-tetrazolones. Chem Pharm Bull 1996, 44, 2, 314.
2 Kitazaki, T.; et al.; Optically active antifungal azoles. IX. An alternative synthetic route for 2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-3(2H,4H)-1,2,4-triazolone and its analogs. Chem Pharm Bull 1999, 47, 3, 360.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(II) 43498 1,1,2,2-tetrafluoro-1-iodopropane C3H3F4I 详情 详情
(III) 43499 4-(2,2,3,3-tetrafluoropropoxy)phenylamine; 4-(2,2,3,3-tetrafluoropropoxy)aniline C9H9F4NO 详情 详情
(IV) 43500 phenyl 4-(2,2,3,3-tetrafluoropropoxy)phenylcarbamate C16H13F4NO3 详情 详情
(V) 43501 N-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-1-hydrazinecarboxamide C10H11F4N3O2 详情 详情
(VI) 15369 Iminoformamide; Methanimidamide 463-52-5 CH4N2 详情 详情
(VII) 43502 4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one C11H9F4N3O2 详情 详情
(VIII) 43503 benzyl (2S)-2-hydroxypropanoate 56777-24-3 C10H12O3 详情 详情
(IX) 43504 benzyl (2S)-2-[[(trifluoromethyl)sulfonyl]oxy]propanoate C11H11F3O5S 详情 详情
(X) 43505 benzyl (2R)-2-[5-oxo-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl]propanoate C21H19F4N3O4 详情 详情
(XI) 43506 (2R)-2-[5-oxo-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-4,5-dihydro-1H-1,2,4-triazol-1-yl]propanoyl chloride C14H12ClF4N3O3 详情 详情
(XII) 13095 m-Difluorobenzene; 1,3-Difluorobenzene 372-18-9 C6H4F2 详情 详情
(XIII) 43507 2-[(1R)-2-(2,4-difluorophenyl)-1-methyl-2-oxoethyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one C20H15F6N3O3 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

The intermediate aniline (IV) was synthesized by Mitsunobu coupling between N-Boc-4-piperidinol (I) and p-nitrophenol (II), followed by catalytic hydrogenation of the resultant nitrophenyl ether (III). 7-Formyl-2-naphthalenecarbonitrile (VI) was prepared by oxidation of the bromomethyl(naphthalene) (V) employing either trimethylamine N-oxide or dimethylsulfoxide in the presence of silver tetrafluoroborate. Reductive alkylation of aniline (IV) with aldehyde (VI) by means of sodium triacetoxyborohydride produced the secondary amine (VII), which was subsequently acylated with ethyl 2-(Chlorosulfonyl)acetate (VIII) to furnish sulfonamide (IX). The required amidine (X) was then obtained by Pinner reaction of nitrile (IX) with ethanolic HCl, followed by treatment with ammonium acetate. The deprotected piperidine moiety of (X) was further subjected to condensation with ethyl acetimidate to give the bis-amidine compound (XI). The ethyl ester group of (XI) was finally hydrolyzed under acidic conditions, yielding the target carboxylic acid.

1 Hirayama, F.; et al.; The discovery of YM-60828: A potent, selective and orally-bioavailable factor Xa inhibitor. Bioorg Med Chem 2002, 10, 5, 1509.
2 Hirayama, F.; Koshio, H.; Matsumoto, Y.; Kawasaki, T.; Kaku, S.; Yanagisawa, I. (Yamanouchi Pharmaceutical Co., Ltd.); Novel amidinonaphthyl derivs. or salt thereof. EP 0798295; US 5869501; WO 9616940 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18625 tert-butyl 4-hydroxy-1-piperidinecarboxylate C10H19NO3 详情 详情
(II) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(III) 55852 tert-butyl 4-(4-nitrophenoxy)-1-piperidinecarboxylate C16H22N2O5 详情 详情
(IV) 55853 tert-butyl 4-(4-aminophenoxy)-1-piperidinecarboxylate C16H24N2O3 详情 详情
(V) 24988 7-(bromomethyl)-2-naphthonitrile C12H8BrN 详情 详情
(VI) 55854 7-formyl-2-naphthonitrile C12H7NO 详情 详情
(VII) 55855 tert-butyl 4-(4-{[(7-cyano-2-naphthyl)methyl]amino}phenoxy)-1-piperidinecarboxylate C28H31N3O3 详情 详情
(VIII) 55856 ethyl 2-(chlorosulfonyl)acetate C4H7ClO4S 详情 详情
(IX) 55857 tert-butyl 4-(4-{[(7-cyano-2-naphthyl)methyl][(2-ethoxy-2-oxoethyl)sulfonyl]amino}phenoxy)-1-piperidinecarboxylate C32H37N3O7S 详情 详情
(X) 55858 ethyl 2-{[({7-[amino(imino)methyl]-2-naphthyl}methyl)-4-(4-piperidinyloxy)anilino]sulfonyl}acetate C27H32N4O5S 详情 详情
(XI) 55859 ethyl 2-({({7-[amino(imino)methyl]-2-naphthyl}methyl)-4-[(1-ethanimidoyl-4-piperidinyl)oxy]anilino}sulfonyl)acetate C29H35N5O5S 详情 详情

合成路线9

该中间体在本合成路线中的序号:(XXII)

Coupling of carbapenem phosphate (VIII) with thiol (XIII) using diisopropylethylamine gave rise to sulfide (XIX). Hydrogenolysis of the p-nitrobenzyl group of (XIX) with simultaneous azide reduction in the presence of Pd/C provided (XX). Treatment of p-nitrobenzyl chloroformate (XXI) with p-nitrophenol (XXII) afforded the nitrophenyl carbonate (XXIII), which was coupled with L-valine (XXIV), yielding carbamate (XXV). Activation of (XXV) with N-hydroxy succinimide and DCC then produced the succinimidyl ester (XXVI). Amine (XX) was coupled with succinimidyl ester (XXVI) to furnish amide (XXVII). The p-nitrobenzyl ester was finally removed by hydrogenation over Pd/C to provide the title compound.

1 Lin, Y.-I.; et al.; Peptidic prodrugs of novel aminomethyl-THF 1beta-methylcarbapenems. Bioorg Med Chem Lett 1997, 7, 13, 1665.
2 Lin, Y.-I.; Bitha, P.; Sakya, S.; Strohmeyer, T.W.; Bush, K. (American Cyanamid Co.); Novel 2-thiosubstd. carbapenems. CA 2118961; EP 0617036; JP 1994321948; US 5602118 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 13224 4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate 90776-59-3 C29H27N2O10P 详情 详情
(XIII) 33047 (2R,3R)-2-(azidomethyl)tetrahydro-3-furanthiol; (2R,3R)-2-(azidomethyl)tetrahydro-3-furanylhydrosulfide C5H9N3OS 详情 详情
(XIX) 33053 4-nitrobenzyl (4R,5S,6S)-3-[[(2R,3R)-2-(azidomethyl)tetrahydro-3-furanyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate C22H25N5O7S 详情 详情
(XX) 33054 (4R,5S,6S)-3-[[(2R,3R)-2-(aminomethyl)tetrahydro-3-furanyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid C15H22N2O5S 详情 详情
(XXI) 33055 1-[[(chlorocarbonyl)oxy]methyl]-4-nitrobenzene 4457-32-3 C8H6ClNO4 详情 详情
(XXII) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(XXIII) 33056 4-nitrobenzyl 4-nitrophenyl carbonate C14H10N2O7 详情 详情
(XXIV) 21056 (R)-(-)-Valine; D-Valine; (R)-alpha-Aminoisovaleric acid 640-68-6 C5H11NO2 详情 详情
(XXV) 33057 (2S)-3-methyl-2-([[(4-nitrobenzyl)oxy]carbonyl]amino)butyric acid C13H16N2O6 详情 详情
(XXVI) 33058 4-nitrobenzyl (1S)-1-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-2-methylpropylcarbamate C17H19N3O8 详情 详情
(XXVII) 33059 (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(2R,3R)-2-([[(2S)-3-methyl-2-([[(4-nitrobenzyl)oxy]carbonyl]amino)butanoyl]amino]methyl)tetrahydro-3-furanyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid C28H36N4O10S 详情 详情

合成路线10

该中间体在本合成路线中的序号:

The reaction of 4-bromothiophene-2-carbaldehyde (I) with triethyl orthoformate gives the corresponding acetal (II), which is treated with NaOMe, CuO and KI in hot methanol yielding 5-methoxythiophene-2-carbaldehyde diethylacetal (III). The hydrolysis of (III) with HCl in methanol affords the carbaldehyde (IV), which is condensed with the phosphonate (V) by means of NaH in THF to provide the ethyl acrylate (VI). The hydrolysis of (VI) with KOH in methanol gives the acrylic acid (VII), which is esterified with 4-nitrophenol, TEA and 2-chloro-1-methylpyridinium iodide in dichloromethane yielding the activate ester (VIII). The condensation of (VIII) with the tetracyclic ketone (IX) (obtained by treatment of the dimeric ketonic compound (X) with NaOMe in methanol) affords the adduct (XI), which is treated with HBr in acetonitrile to open the cyclopropane ring and provide the bromomethyl compound (XII). The aromatization of (XII) with p-nitrophenyl chloroformate (XIII) and TEA in dichloromethane affords the activated carbonate ester (XIV), which is finally treated with 1-methylpiperazine (XV) to furnish the target carbamate.

1 Saito, H.; Kobayashi, E.; Gomi, K.; Okamoto, A.; Nagamura, S.; Amishiro, N.; Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing 5-membered heteroarylacryloyl groups. Chem Pharm Bull 1999, 47, 10, 1393.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(I) 24142 4-bromo-2-thiophenecarbaldehyde 18791-75-8 C5H3BrOS 详情 详情
(II) 38358 (4-bromo-2-thienyl)(ethoxy)methyl ethyl ether; 4-bromo-2-(diethoxymethyl)thiophene C9H13BrO2S 详情 详情
(III) 38359 5-(diethoxymethyl)-3-thienyl methyl ether; 2-(diethoxymethyl)-4-methoxythiophene C10H16O3S 详情 详情
(IV) 35360   C47H75N3O14 详情 详情
(V) 38361 ethyl 2-(dimethoxyphosphoryl)acetate C6H13O5P 详情 详情
(VI) 38362 ethyl (E)-3-(4-methoxy-2-thienyl)-2-propenoate C10H12O3S 详情 详情
(VII) 38363 (E)-3-(4-methoxy-2-thienyl)-2-propenoic acid C8H8O3S 详情 详情
(VIII) 38364 4-nitrophenyl (E)-3-(4-methoxy-2-thienyl)-2-propenoate C14H11NO5S 详情 详情
(IX) 38365 methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C14H14N2O3 详情 详情
(X) 38366 methyl (2R,3bR,4aS)-2-methyl-3,8-dioxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,2,3,4,4a,5,6,8-octahydrocyclopropa[c]pyrrolo[3,2-e]indole-2-carboxylate C26H25N3O8 详情 详情
(XI) 38367 methyl (3bR,4aS)-6-[(E)-3-(4-methoxy-2-thienyl)-2-propenoyl]-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C22H20N2O5S 详情 详情
(XII) 38368 methyl (8S)-8-(bromomethyl)-6-[(E)-3-(4-methoxy-2-thienyl)-2-propenoyl]-2-methyl-4-oxo-3,4,6,7,8,8a-hexahydropyrrolo[3,2-e]indole-1-carboxylate C22H21BrN2O5S 详情 详情
(XIII) 16605 4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene 7693-46-1 C7H4ClNO4 详情 详情
(XIV) 38369 methyl (8S)-8-(bromomethyl)-6-[(E)-3-(4-methoxy-2-thienyl)-2-propenoyl]-2-methyl-4-[[(4-nitrophenoxy)carbonyl]oxy]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate C29H24BrN3O9S 详情 详情
(XV) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情

合成路线11

该中间体在本合成路线中的序号:(V)

The condensation of 5-(benzyloxy)-2,2,4,6,7-pentamethyl-3,4-dihydrobenzofuran-3-ylmethyl methanesulfonate (I) with 2-(methylamino)ethanol (II) by heating at 120 C gives the tertiary amine (III), which is treated with SOCl2 in benzene yielding the chloroethylamino compound (IV). The condensation of (IV) with 4-nitrophenol (V) by means of K2CO3 in hot DMF affords the 4-nitrophenoxy compound (VI), which is reduced with H2 over Pd/C in ethyl acetate to the corresponding 4-aminophenoxy compound (VII). The condensation of (VII) with ethyl acrylate (VIII) by means of NaNO2 and HBr in methanol/water gives the 2-bromopropionic ester (IX), which is cyclized with thiourea (X) by means of NaOAc in refluxing ethanol yielding the thiazolidinedione (XI). Finally, this compound is debenzylated with HCl in hot acetic acid.

1 Casturi, S.R.; Lohray, V.B.; Kallam, A.R.; Pingali, H.; Ramanujam, R.; Alla, S.R. (Dr. Reddy's Research Foundation); Cpds. having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compsns. containing them. US 5925656 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 26455 5-(benzyloxy)-2,2,4,6,7-pentamethyl-3-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-2,3-dihydro-1-benzofuran C24H32O3S 详情 详情
(II) 13324 2-Methylaminoethanol; 2-(Methylamino)-1-ethanol 109-83-1 C3H9NO 详情 详情
(III) 26456 2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]-1-ethanol C24H33NO3 详情 详情
(IV) 26457 N-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]-2-chloro-N-methyl-1-ethanamine C24H32ClNO2 详情 详情
(V) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(VI) 26458 N-[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl]-N-methyl-2-(4-nitrophenoxy)-1-ethanamine C30H36N2O5 详情 详情
(VII) 26459 4-[2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]ethoxy]aniline C30H38N2O3 详情 详情
(VIII) 10164 ethyl acrylate 140-88-5 C5H8O2 详情 详情
(IX) 26460 ethyl 3-(4-[2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]ethoxy]phenyl)-2-bromopropanoate C35H44BrNO5 详情 详情
(X) 10180 Thiourea 62-56-6 CH4N2S 详情 详情
(XI) 26461 5-(4-[2-[[[5-(benzyloxy)-2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-3-yl]methyl](methyl)amino]ethoxy]benzyl)-1,3-thiazolidine-2,4-dione C34H40N2O5S 详情 详情

合成路线12

该中间体在本合成路线中的序号:(II)

The esterification of 3-(benzoylsulfanyl)-2(S)-methylpropionic acid with 4-nitrophenol (II) by means of DCC in dichloromethane gives the corresponding ester (III), which is condensed with S-(4-cyclohexylbenzyl)-L-cysteine (IV) (obtained by alkylation of L-cysteine (V) with 4-cyclohexylbenzyl bromide (VI)) to yield the corresponding amide (VII). Finally, this compound is debenzoylated by a treatment with aqueous NH4OH.

1 Horiuchi, M.; Fujimura, K.; Suhara, H. (Santen Pharmaceutical Co., Ltd.); Novel sulfur-containing amino acid derivs.. EP 0947502; JP 1998130225; US 6046235; WO 9809943 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35379 (2S)-3-(benzoylsulfanyl)-2-methylpropionic acid C11H12O3S 详情 详情
(II) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(III) 35380 4-nitrophenyl (2S)-3-(benzoylsulfanyl)-2-methylpropanoate C17H15NO5S 详情 详情
(IV) 35381 (2R)-2-amino-3-[(4-cyclohexylbenzyl)sulfanyl]propionic acid C16H23NO2S 详情 详情
(V) 14643 L-cysteine; (R)-2-Amino-3-mercaptopropionic acid 52-90-4 C3H7NO2S 详情 详情
(VI) 35382 1-(bromomethyl)-4-cyclohexylbenzene C13H17Br 详情 详情
(VII) 35383 (2R)-2-[[(2S)-3-(benzoylsulfanyl)-2-methylpropanoyl]amino]-3-[(4-cyclohexylbenzyl)sulfanyl]propionic acid C27H33NO4S2 详情 详情

合成路线13

该中间体在本合成路线中的序号:(VII)

The reaction of 2-chloropyrimidine (I) with NaOMe in methanol gives 2-methoxypyrimidine (II), which is iodinated with N-iodosuccinimide (NIS) and trifluoroacetic anhydride in refluxing THF to yield 5-iodo-2-methoxypyrimidine (III). The condensation of (III) with methyl acrylate (IV) by means of Pd(OAc)2, K2CO3 and Bu4NCl at 120 C affords 3-(2-methoxypyrimidin-5-yl)acrylic acid methyl ester (V), which is hydrolyzed with KOH in methanol to provide the free acid (VI). The esterification of (VI) with p-nitrophenol (VII) by means of DCC and DMAP in dichloromethane gives the activate ester (VIII). The condensation of (VIII) with the tetracyclic ketone (IX) (obtained by treatment of the dimeric ketonic compound (X) with NaOMe in methanol) affords the adduct (XI), which is treated with HBr in acetonitrile to open the cyclopropane ring and provide the bromomethyl compound (XII). The aromatization of (XII) with p-nitrophenyl chloroformate (XIII) and TEA in dichloromethane affords the activated carbonate ester (XIV), which is finally treated with 1-methylpiperazine (XV) to furnish the target carbamate.

1 Nagamura, S.; et al.; Synthesis and antitumor activity of duocarmycin derivatives: Modification of affinity moiety to DNA minor groove. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 206.
2 Saito, H.; Nagamura, S.; Amishiro, N.; Kobayashi, E.; Gomi, K.; New water-soluble duocarmycin derivatives: Synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups. J Med Chem 1999, 42, 4, 669.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11191 2-Chloropyrimidine 1722-12-9 C4H3ClN2 详情 详情
(II) 38398 methyl 2-pyrimidinyl ether; 2-methoxypyrimidine C5H6N2O 详情 详情
(III) 38394 5-iodo-2-methoxypyrimidine; 5-iodo-2-pyrimidinyl methyl ether C5H5IN2O 详情 详情
(IV) 14156 methyl acrylate 96-33-3 C4H6O2 详情 详情
(V) 38395 methyl (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoate C9H10N2O3 详情 详情
(VI) 38396 (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoic acid C8H8N2O3 详情 详情
(VII) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(VIII) 38397 4-nitrophenyl (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoate C14H11N3O5 详情 详情
(IX) 38365 methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C14H14N2O3 详情 详情
(X) 38366 methyl (2R,3bR,4aS)-2-methyl-3,8-dioxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,2,3,4,4a,5,6,8-octahydrocyclopropa[c]pyrrolo[3,2-e]indole-2-carboxylate C26H25N3O8 详情 详情
(XI) 38399 methyl (3bR,4aS)-6-[(E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoyl]-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C22H20N4O5 详情 详情
(XII) 38400 methyl (8S)-8-(bromomethyl)-6-[(E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoyl]-2-methyl-4-oxo-3,4,6,7,8,8a-hexahydropyrrolo[3,2-e]indole-1-carboxylate C22H21BrN4O5 详情 详情
(XIII) 16605 4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene 7693-46-1 C7H4ClNO4 详情 详情
(XIV) 38401 methyl (8S)-8-(bromomethyl)-6-[(E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoyl]-2-methyl-4-[[(4-nitrophenoxy)carbonyl]oxy]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate C29H24BrN5O9 详情 详情
(XV) 10061 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine 109-01-3 C5H12N2 详情 详情

合成路线14

该中间体在本合成路线中的序号:(VII)

The reaction of 2-chloropyrimidine (I) with NaOMe in methanol gives 2-methoxypyrimidine (II), which is iodinated with N-iodosuccinimide (NIS) and trifluoroacetic anhydride in refluxing THF to yield 5-iodo-2-methoxypyrimidine (III). The condensation of (III) with methyl acrylate (IV) by means of Pd(OAc)2, K2CO3 and Bu4NCl at 120 C affords 3-(2-methoxypyrimidin-5-yl)acrylic acid methyl ester (V), which is hydrolyzed with KOH in methanol to provide the free acid (VI). The esterification of (VI) with p-nitrophenol (VII) by means of DCC and DMAP in dichloromethane gives the activate ester (VIII). Finally, the condensation of (VIII) with the tetracyclic ketone (IX) (obtained by treatment of the dimeric ketonic compound (X) with NaOMe in methanol) affords the target compound.

1 Saito, H.; Nagamura, S.; Amishiro, N.; Kobayashi, E.; Gomi, K.; New water-soluble duocarmycin derivatives: Synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups. J Med Chem 1999, 42, 4, 669.
2 Nagamura, S.; et al.; Synthesis and antitumor activity of duocarmycin derivatives: Modification of affinity moiety to DNA minor groove. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 206.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11191 2-Chloropyrimidine 1722-12-9 C4H3ClN2 详情 详情
(II) 38398 methyl 2-pyrimidinyl ether; 2-methoxypyrimidine C5H6N2O 详情 详情
(III) 38394 5-iodo-2-methoxypyrimidine; 5-iodo-2-pyrimidinyl methyl ether C5H5IN2O 详情 详情
(IV) 14156 methyl acrylate 96-33-3 C4H6O2 详情 详情
(V) 38395 methyl (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoate C9H10N2O3 详情 详情
(VI) 38396 (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoic acid C8H8N2O3 详情 详情
(VII) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(VIII) 38397 4-nitrophenyl (E)-3-(2-methoxy-5-pyrimidinyl)-2-propenoate C14H11N3O5 详情 详情
(IX) 38365 methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C14H14N2O3 详情 详情
(X) 38366 methyl (2R,3bR,4aS)-2-methyl-3,8-dioxo-6-[(5,6,7-trimethoxy-1H-indol-2-yl)carbonyl]-1,2,3,4,4a,5,6,8-octahydrocyclopropa[c]pyrrolo[3,2-e]indole-2-carboxylate C26H25N3O8 详情 详情

合成路线15

该中间体在本合成路线中的序号:(I)

The reaction of 4-nitrophenol (I) with 1,5-dibromopentane (II) and NaOH in refluxing water gives the aryl ether (III), which is finally condensed with pyrrolidine (IV) in refluxing ethanol.

1 Ganellin, C.; et al.; Synthesis of potent non-imidazole histamine H3-receptor antagonists. Arch Pharm 1998, 331, 12, 395.
2 Stark, H.; Ligneau, X.; Garbarg, M.; Schunack, W.G.; Ganellin, C.R.; Lecomte, J.-M.; Arrang, J.-M.; Leurquin, F.; Sigurd, E.; Schwartz, J.-C. (Societe Civile Bioprojet); Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications. EP 0978512 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(II) 30560 1,5-dibromopentane 111-24-0 C5H10Br2 详情 详情
(III) 46286 1-[(5-bromopentyl)oxy]-4-nitrobenzene; 5-bromopentyl 4-nitrophenyl ether C11H14BrNO3 详情 详情
(IV) 11376 Pyrrolidine 123-75-1 C4H9N 详情 详情

合成路线16

该中间体在本合成路线中的序号:(IX)

Alkylation of 5-methoxy-2-methylindole (I) with iodomethane and NaH afforded the 1,2-dimethyl derivative (II). Subsequent Vilsmeier formylation of (II) employing N-methylformanilide and POCl3 furnished aldehyde (III). Nitration of (III) to (IV), followed by reduction with Sn and HCl gave aminoindole (V), which was oxidized to the corresponding quinone (VI) by using a buffered solution of Fremy's salt. Aldehyde (VI) reduction with NaBH4 provided alcohol (VII). This was optionally converted to the chloromethyl derivative (VIII) upon treatment with SOCl2. The title p-nitrophenyl ether was either obtained by alkylation of 4-nitrophenol (IX) with chloride (VIII) or by Mitsunobu coupling of 4-nitrophenol (IX) with indole alcohol (VII).

1 Beall, H.D.; Winski, S.; Swann, E.; Hudnott, A.R.; Cotterill, A.S.; O'Sullivan, N.; Green, S.J.; Bien, R.; Siegel, D.; Ross, D.; Moody, C.J.; Indolequinone antitumor agents: Correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity. J Med Chem 1998, 41, 24, 4755.
2 Stratford, I.J.; Naylor, M.A.; Jaffar, M.; Adams, G.E. (BTG plc); Indoloquinone derivs. as bioreductive agents. WO 9723456 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 38842 5-Methoxy-2-methyl-1H-indole; Methyl 2-methyl-1H-indol-5-yl ether 1076-74-0 C10H11NO 详情 详情
(II) 38843 1,2-dimethyl-1H-indol-5-yl methyl ether; 5-methoxy-1,2-dimethyl-1H-indole C11H13NO 详情 详情
(III) 38844 5-methoxy-1,2-dimethyl-1H-indole-3-carbaldehyde C12H13NO2 详情 详情
(IV) 38845 5-methoxy-1,2-dimethyl-4-nitro-1H-indole-3-carbaldehyde C12H12N2O4 详情 详情
(V) 38846 4-amino-5-methoxy-1,2-dimethyl-1H-indole-3-carbaldehyde C12H14N2O2 详情 详情
(VI) 38847 5-methoxy-1,2-dimethyl-4,7-dioxo-4,7-dihydro-1H-indole-3-carbaldehyde C12H11NO4 详情 详情
(VII) 26107 3-(hydroxymethyl)-5-methoxy-1,2-dimethyl-1H-indole-4,7-dione C12H13NO4 详情 详情
(VIII) 38848 3-(chloromethyl)-5-methoxy-1,2-dimethyl-1H-indole-4,7-dione C12H12ClNO3 详情 详情
(IX) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情

合成路线17

该中间体在本合成路线中的序号:(II)

8-Methoxy-2-trifluoromethylquinoline-5-carboxylic acid (I) was activated as the corresponding nitrophenyl ester (III) upon treatment with p-nitrophenol (II) and EDC. The p-nitrophenyl ester (III) was then coupled with 4-amino-3,5-dichloropyridine (IV) in the presence of NaH to produce amide (V). The pyridine ring of (V) was finally oxidized to the title N-oxide by treatment with peracetic acid.

1 Billah, M.; et al.; Synthesis and profile of SCH351591, a novel PDE4 inhibitor. Bioorg Med Chem Lett 2002, 12, 12, 1621.
2 Montana, J.G.; Dyke, H.J. (Celltech Group plc); N-Oxides of heterocyclic cpds. with TNF and PDE-IV inhibiting activity. EP 1045845; US 6262070; WO 0026208 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52889 8-methoxy-2-(trifluoromethyl)-5-quinolinecarboxylic acid C12H8F3NO3 详情 详情
(II) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(III) 52890 4-nitrophenyl 8-methoxy-2-(trifluoromethyl)-5-quinolinecarboxylate C18H11F3N2O5 详情 详情
(IV) 25135 3,5-dichloro-4-pyridinamine; 4-amino-3,5-dichloropyridine 22889-78-7 C5H4Cl2N2 详情 详情
(V) 52891 N-(3,5-dichloro-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinolinecarboxamide C17H10Cl2F3N3O2 详情 详情

合成路线18

该中间体在本合成路线中的序号:(XI)

The protection of the OH group of 4-hydroxy-3,5-dimethoxybenzaldehyde (I) with benzyl bromide and K2CO3 DMF gives the benzyl ether (II), which is condensed with ethyl 2-azidoacetate (III) by means of NaOMe in methanol to yield the 2-azido acrylic acid derivative (IV). The cyclization of (IV) in refluxing xylene affords the indole carboxylate (V), which is deprotected by hydrogenation with H2 over PtO2 in THF/methanol to provide 6-hydroxy-5,7-dimethoxy-1H-indole-2-carboxylic acid methyl ester (I). The condensation of (VI) with 1,2-dibromoethane (VII) by means of K2CO3 in DMF gives the 2-bromoethoxy derivative (VIII), which is treated with sodium azide in DMF to yield the 2-azidoethoxy compound (IX). The hydrolysis of the ester group of (IX) with NaOH in THF/water affords the carboxylic acid (X), which is esterified with 4-nitrophenol (XI) by means of DCC and DMAP in dichloromethane to provide the activated ester (XII). The condensation of (XII) with the tetracyclic compound (XIII) by means of NaH in DMF gives the adduct (XIV), which is finally reduced at the azido group with H2 over Pd/C in THF/HOAc to yield the target compound.

1 Suzawa, T.; et al.; Synthesis of a novel duocarmycin derivative DU-257 and its application to immunoconjugate using poly(ethylene glycol-dipeptidyl linker capable of tumor specific activation. Bioorg Med Chem 2000, 8, 8, 2175.
2 Saito, H.; Nagamura, S.; Suzawa, T.; Yamasaki, M.; Ohta, S.; Hanai, N. (Kyowa Hakko Kogyo Co., Ltd.); Toxin conjugates. US 6103236; WO 9635451 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49243 3,5-Dimethoxy-4-hydroxybenzaldehyde; 4-Hydroxy-3,5-dimethoxybenzaldehyde; Syringaldehyde 134-96-3 C9H10O4 详情 详情
(II) 49244 4-Benzyloxy-3,5-dimethoxybenzaldehyde C16H16O4 详情 详情
(III) 49245 alpha-azido acetic acid methyl ester C3H5N3O2 详情 详情
(IV) 49246 methyl (Z)-2-azido-3-[4-(benzyloxy)-3,5-dimethoxyphenyl]-2-propenoate C19H19N3O5 详情 详情
(V) 49247 methyl 6-(benzyloxy)-5,7-dimethoxy-1H-indole-2-carboxylate C19H19NO5 详情 详情
(VI) 49248 methyl 6-hydroxy-5,7-dimethoxy-1H-indole-2-carboxylate C12H13NO5 详情 详情
(VII) 10252 1,2-Dibromoethane; Ethylene dibromide 106-93-4 C2H4Br2 详情 详情
(VIII) 49249 methyl 6-(2-bromoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylate C14H16BrNO5 详情 详情
(IX) 49250 methyl 6-(2-azidoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylate C14H16N4O5 详情 详情
(X) 49251 6-(2-azidoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylic acid C13H14N4O5 详情 详情
(XI) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(XII) 49252 4-nitrophenyl 6-(2-azidoethoxy)-5,7-dimethoxy-1H-indole-2-carboxylate C19H17N5O7 详情 详情
(XIII) 38365 methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C14H14N2O3 详情 详情
(XIV) 49253 methyl (3bR,4aS)-6-[[6-(2-azidoethoxy)-5,7-dimethoxy-1H-indol-2-yl]carbonyl]-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C27H26N6O7 详情 详情

合成路线19

该中间体在本合成路线中的序号:(I)

Treatment of p-nitrophenol (I) with 1-chloroethyl chloroformate (II) in the presence of pyridine afforded carbonate (III). Subsequent displacement of the chlorine atom of (III) with mercuric acetate in HOAc provided the acetoxy derivative (IV). This was then condensed with (R)-alpha-methylhistamine (V) in HMPT to furnish the title compound.

1 Stark, H.; et al.; Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-alpha-methylhistamine. Bioorg Med Chem 2001, 9, 1, 191.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(II) 22014 1-chloro-1-[(chlorocarbonyl)oxy]ethane 50893-53-3 C3H4Cl2O2 详情 详情
(III) 51393 1-chloroethyl 4-nitrophenyl carbonate C9H8ClNO5 详情 详情
(IV) 50378 1-[[(4-nitrophenoxy)carbonyl]oxy]ethyl acetate C11H11NO7 详情 详情
(V) 51394 (2R)-1-(1H-imidazol-4-yl)-2-propanamine; (1R)-2-(1H-imidazol-4-yl)-1-methylethylamine C6H11N3 详情 详情

合成路线20

该中间体在本合成路线中的序号:(II)

Coupling between 2-chloro-5-nitropyridine (I) and 4-nitrophenol (II) affords the diaryl ether (III). Subsequent catalytic hydrogenation of both nitro groups of (III) gives rise to diamine (IV). This is finally acylated with (S)-2,2-dimethylcyclopropanecarbonyl chloride (V) to furnish the title diamide.

1 Yamamoto, T.; Iino, Y.; Kobayashi, T.; Fujita, K.; Hatanaka, T.; Kodaira, A.; Takehana, K.; Konishi, A. (Ajinomoto Co., Inc.); Heterocyclic cpds. and medicinal use thereof. EP 1193255; WO 0102359 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29610 2-chloro-5-nitropyridine 4548-45-2 C5H3ClN2O2 详情 详情
(II) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(III) 57425 4-nitrophenyl 5-nitro-2-pyridinyl ether; 5-nitro-2-(4-nitrophenoxy)pyridine C11H7N3O5 详情 详情
(IV) 57426 6-(4-aminophenoxy)-3-pyridinamine; 6-(4-aminophenoxy)-3-pyridinylamine C11H11N3O 详情 详情
(V) 57427 (1S)-2,2-dimethylcyclopropanecarbonyl chloride C6H9ClO 详情 详情

合成路线21

该中间体在本合成路线中的序号:(X)

Alkylation of 2,5-dichlorothiophenol (I) with bromoacetaldehyde diethyl acetal (II) produced thioether (III). Benzothiophene (IV) was then obtained by cyclization of (III) under Friedel-Crafts conditions in the presence of polyphosphoric acid. Metalation of benzothiophene (IV) with BuLi at -78 C, followed by addition of sulfur dioxide gave rise to the sulfinic acid (V). This was converted to the sulfonyl chloride (VI) by chlorination with N-chlorosuccinimide, and further treatment of (VI) with ammonium hydroxide provided the sulfonamide (VII). Addition of formaldehyde to the benzothiophene-2-sulfonamide (VII), followed by condensation with trimethyl phosphite, furnished the dimethyl (sulfonamidomethyl)phosphonate (VIII). The phosphonate ester function of (VIII) was then hydrolyzed by means of bromotrimethylsilane, producing phosphonic acid (IX). This was finally coupled to 4-nitrophenol (X) using trichloroacetonitrile in hot pyridine to afford the title mono-phosphonate ester.

1 Delorme, D.; Besterman, J.M.; Rahil, J. (MethylGene Inc.); Sulfonamidomethyl phosphonate inhibitors of beta-lactamase. EP 1194436; WO 0102411 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54802 2,5-Dichlorobenzenethiol; 2,5-Dichlorophenylmercaptan; 2,5-Dichlorothiophenol 5858-18-4 C6H4Cl2S 详情 详情
(II) 12113 2-Bromo-1-ethoxyethyl ethyl ether; 2-Bromo-1,1-diethoxyethane; Bromoacetaldehyde diethylacetal 2032-35-1 C6H13BrO2 详情 详情
(III) 54803 2-[(2,5-dichlorophenyl)sulfanyl]-1-ethoxyethyl ethyl ether; 1,4-dichloro-2-[(2,2-diethoxyethyl)sulfanyl]benzene C12H16Cl2O2S 详情 详情
(IV) 54804 4,7-dichloro-1-benzothiophene C8H4Cl2S 详情 详情
(V) 54805 4,7-dichloro-1-benzothiophene-2-sulfinic acid C8H4Cl2O2S2 详情 详情
(VI) 54806 4,7-dichloro-1-benzothiophene-2-sulfonyl chloride C8H3Cl3O2S2 详情 详情
(VII) 54807 4,7-dichloro-1-benzothiophene-2-sulfonamide C8H5Cl2NO2S2 详情 详情
(VIII) 54808 dimethyl {[(4,7-dichloro-1-benzothiophen-2-yl)sulfonyl]amino}methylphosphonate C11H12Cl2NO5PS2 详情 详情
(IX) 54809 {[(4,7-dichloro-1-benzothiophen-2-yl)sulfonyl]amino}methylphosphonic acid C9H8Cl2NO5PS2 详情 详情
(X) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情

合成路线22

该中间体在本合成路线中的序号:(V)

Two new syntheses for amoscanate have been described: 1) The reaction of 4-isothiocyanatobenzoyl chloride (I) with sodium azide (II) gives 4-isothiocyanatobenzoyl azide (III), which by heating in chlorobenzene is converted into 4-isothiocyanatophenyl isocyanate (IV). Finally this compound is condensed with 4-nitrophenol (V) by heating at 190 C. 2) By condensation of 1,4-phenylenebisisothiocyanate (VI) with 4-nitrophenol (V) at 190 C as before.

1 IN 150073 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 60780 4-isothiocyanatobenzoyl chloride C8H4ClNOS 详情 详情
(III) 60781 4-isothiocyanatobenzoyl azide C8H4N4OS 详情 详情
(IV) 60782 1-isocyanato-4-isothiocyanatobenzene; 4-isothiocyanatophenyl isocyanate C8H4N2OS 详情 详情
(V) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(VI) 60783 1,4-diisothiocyanatobenzene; 4-isothiocyanatophenyl isothiocyanate C8H4N2S2 详情 详情

合成路线23

该中间体在本合成路线中的序号:(IX)

Aspartic acid (I) was esterified with benzyl alcohol to afford the beta-benzyl ester (II). Dakin-West reaction of (II) with Ac2O and Et3N yielded the amido ketone (III). Acidic hydrolysis of (III), followed by re-esterification with EtOH, furnished amino ester (IV), which was acylated with acyl chloride (V), producing amide (VI). Cyclization between the amide and ketone groups of (VI) using Ac2O as the dehydrating reagent gave rise to the isoxazole (VII). The ester group of (VII) was then reduced to alcohol (VIII) with NaBH4 in the presence of AlCl3. Coupling of alcohol (VIII) with 4-nitrophenol (IX) to furnish ether (X) was effected either by Mitsunobu coupling or via previous conversion of (VIII) to the corresponding tosylate, followed by condensation with phenol (IX) under Williamson's ether synthesis conditions. Catalytic hydrogenation of the nitro group of (X) led to the aniline (XI). Finally, acylation of (XI) with trifluoromethanesulfonic anhydride provided the target sulfonamide.

1 Tomiyama, H.; et al.; Non-thiazolidinedione PPAR gamma- and alpha-dual agonists for the treatment of type II Diabetes mellitus. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 38.
2 Kuroiwa, K.; Tomiyama, T.; Tomiyama, H.; Tomiyama, T. (Kotobuki Pharmaceutical Co., Ltd.); Ether or amide derivs., their preparation method and therapeutic agent for diabetes containing them. DE 10100772; JP 2001261662 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 51614 DL-2-Aminobutanedioic acid; DL-Aminosuccinic acid; DL-Asparaginic Acid; (+/-)-2-Aminosuccinic acid; DL-Aspartic acid; D,L-Aspartic acid 617-45-8 C4H7NO4 详情 详情
(II) 51606 Aspartic acid, 4-benzyl ester; L-Aspartic acid gamma-benzyl ester; beta-Benzyl L-aspartate 2177-63-1 C11H13NO4 详情 详情
(III) 51607 benzyl 3-(acetamido)-4-oxopentanoate C14H17NO4 详情 详情
(IV) 51608 ethyl 3-amino-4-oxopentanoate C7H13NO3 详情 详情
(V) 36133 3,5-di(tert-butyl)-4-hydroxybenzoyl chloride C15H21ClO2 详情 详情
(VI) 51609 ethyl 3-[[3,5-di(tert-butyl)-4-hydroxybenzoyl]amino]-4-oxopentanoate C22H33NO5 详情 详情
(VII) 51610 ethyl 2-[2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-5-methyl-1,3-oxazol-4-yl]acetate C22H31NO4 详情 详情
(VIII) 51611 2,6-di(tert-butyl)-4-[4-(2-hydroxyethyl)-5-methyl-1,3-oxazol-2-yl]phenol C20H29NO3 详情 详情
(IX) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(X) 51612 2,6-di(tert-butyl)-4-[5-methyl-4-[2-(4-nitrophenoxy)ethyl]-1,3-oxazol-2-yl]phenol C26H32N2O5 详情 详情
(XI) 51613 4-[4-[2-(4-aminophenoxy)ethyl]-5-methyl-1,3-oxazol-2-yl]-2,6-di(tert-butyl)phenol C26H34N2O3 详情 详情

合成路线24

该中间体在本合成路线中的序号:(II)

5-Nitrobenzofuran-2-carboxylic acid (I) is coupled to 4-nitrophenol (II) in the presence of EDC to produce the p-nitrophenyl ester (III). Subsequent acylation of the duocarmycin derivative (IV) with active ester (III) leads to amide (V). Cyclopropane ring opening in (V) with HCl in DMF furnishes the chloromethyl derivative (VI). The nitro group of (VI) is then reduced by catalytic hydrogenation, yielding amine (VII). Acylation of (VII) with 7-nitroindole-2-carboxylic acid (VIII) affords the corresponding amide (IX)

1 McGee, D.P.C.; Saunders, O.L.; Martichonok, V.; Wu, G.; Ng, H.P.; Li, Z.; Yarranton, G.T. (Medarex, Inc.); Cytotoxic agents. US 2003050331; WO 0296910 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 63365 5-nitro-1-benzofuran-2-carboxylic acid 10242-12-3 C9H5NO5 详情 详情
(II) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(III) 63440 4-nitrophenyl 5-nitro-1-benzofuran-2-carboxylate C15H8N2O7 详情 详情
(IV) 38365 methyl (3bR,4aS)-2-methyl-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C14H14N2O3 详情 详情
(V) 63441 methyl 2-methyl-6-[(5-nitro-1-benzofuran-2-yl)carbonyl]-8-oxo-1,4,4a,5,6,8-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-3-carboxylate C23H17N3O7 详情 详情
(VI) 63442 methyl 8-(chloromethyl)-4-hydroxy-2-methyl-6-[(5-nitro-1-benzofuran-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate C23H18ClN3O7 详情 详情
(VII) 63443 methyl 6-[(5-amino-1-benzofuran-2-yl)carbonyl]-8-(chloromethyl)-4-hydroxy-2-methyl-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate C23H20ClN3O5 详情 详情
(VIII) 63444 7-nitro-1H-indole-2-carboxylic acid C9H6N2O4 详情 详情
(IX) 63445 methyl 8-(chloromethyl)-4-hydroxy-2-methyl-6-[(5-{[(7-nitro-1H-indol-2-yl)carbonyl]amino}-1-benzofuran-2-yl)carbonyl]-3,6,7,8-tetrahydropyrrolo[3,2-e]indole-1-carboxylate C32H24ClN5O8 详情 详情

合成路线25

该中间体在本合成路线中的序号:(IV)

Addition of formaldehyde to 5,7-dichlorobenzothiophene-2-sulfonamide (I), followed by condensation with trimethyl phosphite, furnished the dimethyl (sulfonamidomethyl) phosphonate (II). The phosphonate ester function of (II) was then hydrolyzed by means of bromotrimethylsilane, producing phosphonic acid (III). This was finally coupled to 4-nitrophenol (IV) using trichloroacetonitrile in hot pyridine to afford the title mono-phosphonate ester.

1 Delorme, D.; Besterman, J.M.; Rahil, J. (MethylGene Inc.); Sulfonamidomethyl phosphonate inhibitors of beta-lactamase. EP 1194436; WO 0102411 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54795 5,7-dichloro-1-benzothiophene-2-sulfonamide C8H5Cl2NO2S2 详情 详情
(II) 54796 dimethyl {[(5,7-dichloro-1-benzothiophen-2-yl)sulfonyl]amino}methylphosphonate C11H12Cl2NO5PS2 详情 详情
(III) 54797 {[(5,7-dichloro-1-benzothiophen-2-yl)sulfonyl]amino}methylphosphonic acid C9H8Cl2NO5PS2 详情 详情
(IV) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情

合成路线26

该中间体在本合成路线中的序号:(IV)

Reduction of 3-(3,5-di-t-butyl-4-hydroxyphenyl)propionic acid (I) with LiAlH4 afforded alcohol (II), which was further brominated to (III) using PBr3. Alkylation of p-nitrophenol (IV) by the alkyl bromide (III) gave ether (V). Then, reduction of the nitro group of (V) to the aniline (VI) was accomplished by means of hydrazine in the presence of Raney nickel.

1 Aubriot, S.; et al.; New series of aryloxypropanolamines with both human beta3-adrenoceptor agonistic activity and free radical scavenging properties. Bioorg Med Chem Lett 2002, 12, 2, 209.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 43376 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propionic acid 20170-32-5 C17H26O3 详情 详情
(II) 41518 2,6-di(tert-butyl)-4-(3-hydroxypropyl)phenol C17H28O2 详情 详情
(III) 59677 4-(3-bromopropyl)-2,6-di(tert-butyl)phenol C17H27BrO 详情 详情
(IV) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(V) 59678 2,6-di(tert-butyl)-4-[3-(4-nitrophenoxy)propyl]phenol C23H31NO4 详情 详情
(VI) 59679 4-[3-(4-aminophenoxy)propyl]-2,6-di(tert-butyl)phenol C23H33NO2 详情 详情

合成路线27

该中间体在本合成路线中的序号:(II)

 

1 R4jendra GL, Pang NG, Maya JS, et al. 2004. Improved process for preparation of thiazolidinedione derivatives. W0 2004024059
2 Sohda T, Momose Y, Meguro K, et al. 1990. Studies on antidiabetic agents Synthesis and hypoglycemic activity of 5-[4-(pyridylaIkoxy) benzyl]-2,4-thiazolidinediones. Arzneim-Forsch, 40: 37~42
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 62866 2-(5-ethyl-2-pyridinyl)ethyl methanesulfonate C10H15NO3S 详情 详情
(II) 11236 4-Nitrophenol; p-Nitrophenol 100-02-7 C6H5NO3 详情 详情
(III) 62867 5-ethyl-2-[2-(4-nitrophenoxy)ethyl]pyridine; 2-(5-ethyl-2-pyridinyl)ethyl 4-nitrophenyl ether C15H16N2O3 详情 详情
(IV) 62868 4-[2-(5-ethyl-2-pyridinyl)ethoxy]aniline; 4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenylamine C15H18N2O 详情 详情
(V) 66597 4-(2-(5-ethylpyridin-2-yl)ethoxy)benzenediazonium   C15H16N3O 详情 详情
(VI) 14156 methyl acrylate 96-33-3 C4H6O2 详情 详情
(VII) 66598 methyl 3-(4-(2-(5-ethylpyridin-2-yl)ethoxy)phenyl)propanoate   C19H23NO3 详情 详情
Extended Information